A citation-based method for searching scientific literature

Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Silvio E Inzucchi. N Engl J Med 2015
Times Cited: 5013



Christopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, James Mancuso, Susan Huyck, Urszula Masiukiewicz, Bernard Charbonnel, Robert Frederich, Silvina Gallo, Francesco Cosentino, Weichung J Shih, Ira Gantz, Steven G Terra, David Z I Cherney, Darren K McGuire. N Engl J Med 2020
Times Cited: 246




List of shared articles



Times cited

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis.
Darren K McGuire, Weichung J Shih, Francesco Cosentino, Bernard Charbonnel, David Z I Cherney, Samuel Dagogo-Jack, Richard Pratley, Michelle Greenberg, Shuai Wang, Susan Huyck,[...]. JAMA Cardiol 2021
75

Guideline recommendations and the positioning of newer drugs in type 2 diabetes care.
Nikolaus Marx, Melanie J Davies, Peter J Grant, Chantal Mathieu, John R Petrie, Francesco Cosentino, John B Buse. Lancet Diabetes Endocrinol 2021
19

Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes.
Ronald M Goldenberg, Vineeta Ahooja, Kristin K Clemens, Jeremy D Gilbert, Megha Poddar, Subodh Verma. Can J Diabetes 2021
1

The role of sodium glucose co-transporter inhibitors in heart failure prevention.
Vishnu Garla, Angela Subauste, Javed Butler, Lillian F Lien. J Diabetes Complications 2021
0

Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
Shruti S Joshi, Trisha Singh, David E Newby, Jagdeep Singh. Heart 2021
7

Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin.
Ricardo Fontes-Carvalho, Diogo Santos-Ferreira, Itamar Raz, Nikolaus Marx, Frank Ruschitzka, Francesco Cosentino. Eur J Prev Cardiol 2021
1

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J L Heersprink, Mikhail Kosiborod, Christoph Wanner, Eberhard Standl. Cardiovasc Diabetol 2021
1


Cardiorenal Protection in Diabetic Kidney Disease.
Jason F Lee, Ecaterina Berzan, Vikas S Sridhar, Ayodele Odutayo, David Z I Cherney. Endocrinol Metab (Seoul) 2021
2

Emerging Pharmacologic Therapies for Heart Failure With Reduced Ejection Fraction.
Ammar G Chaudhary, Fadi M Alreefi, Mohammad A Aziz. CJC Open 2021
0

De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study.
Luis M Pérez-Belmonte, Michele Ricci, Jaime Sanz-Cánovas, Lidia Cobos-Palacios, María D López-Carmona, M Isabel Ruiz-Moreno, Mercedes Millán-Gómez, M Rosa Bernal-López, Sergio Jansen-Chaparro, Ricardo Gómez-Huelgas. J Clin Med 2021
0

Sodium-glucose cotransporter 2 inhibition in non-diabetic kidney disease.
Mohanad Almaimani, Vikas S Sridhar, David Z I Cherney. Curr Opin Nephrol Hypertens 2021
0

Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials.
David Z I Cherney, Samuel Dagogo-Jack, Darren K McGuire, Francesco Cosentino, Richard Pratley, Weichung J Shih, Robert Frederich, Mario Maldonado, Jie Liu, Shuai Wang,[...]. Clin Cardiol 2021
1

Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience.
K Zwart, S Velthuis, Y V Polyukhovych, A Mosterd, L Smidt, E H Serné, D H van Raalte, P J M Elders, M L Handoko, P C Oldenburg-Ligtenberg. Neth Heart J 2021
1

Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021.
Fabiana G Marcondes-Braga, Lídia Ana Zytynski Moura, Victor Sarli Issa, Jefferson Luis Vieira, Luis Eduardo Rohde, Marcus Vinícius Simões, Miguel Morita Fernandes-Silva, Salvador Rassi, Silvia Marinho Martins Alves, Denilson Campos de Albuquerque,[...]. Arq Bras Cardiol 2021
1

SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications.
Emily Brown, Hiddo J L Heerspink, Daniel J Cuthbertson, John P H Wilding. Lancet 2021
3


Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis.
Wen-Hsuan Tsai, Shih-Ming Chuang, Sung-Chen Liu, Chun-Chuan Lee, Ming-Nan Chien, Ching-Hsiang Leung, Shu-Jung Liu, Hong-Mou Shih. Sci Rep 2021
1





2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno,[...]. Eur J Prev Cardiol 2021
0

JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito,[...]. J Card Fail 2021
0